Medicare Price Inflation Rebates Levied On 27 Part B Drugs In First Round; Pfizer Tops The List

Biden Administration releases first list of Part B drugs subject to inflation rebates; others to follow on quarterly basis. Medicare won’t invoice sponsors until 2025, but patients could see coinsurance reductions next month.

Penalties On Price Increases For Physician Administered Drugs • Source: Shutterstock

More from Market Access

More from Pink Sheet